News

04 2018 Sep

PRESS RELEASE: Congestive Heart Failure Patients Benefit from Oxygen Therapy: Uni-flo2 Promotes Treatment Compliance while Enhancing Personal Appearance 

LEHIGH VALLEY, PA – September 4, 2018 – Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, points to its benefits for patients with congestive heart failure (CHF) who require supplemental oxygen therapy. CHF patients welcome an inconspicuous, lightweight single cannula that not only may optimize oxygen absorption and improve health, but also introduces a life-changing enhancement for improved appearance.

“Treatment compliance is critical to ensure that the CHF patient is getting enough oxygen, and the introduction of the Uni-flo2 single cannula supports this objective,” says Campbell Cauthen, Registered Respiratory Therapist and co-inventor, Uni-flo2. “Patients living with CHF may also experience chronic obstructive pulmonary disease and have difficulty breathing.  With continuous reliance upon supplemental oxygen therapy, these patients appreciate greater comfort and freedom of movement when utilizing the Uni-flo2.  Of course, enhanced personal appearance is always appreciated by men and women alike.”

Nasal cannulas and face masks are typically used in treatment of people who have respiratory related conditions such as asthma, pneumonia, and cardiac issues.

“Uni-flo2  is designed to conform to facial contours which eliminates facial and neck irritation,” adds Cauthen.  “Our growing community of patients also report improved sleep and ability to eat and smell.  It’s always gratifying to hear from patients who tell us that they especially like the way they look with a single cannula.”

About Uni-flo2

Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous low flow oxygen equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348. Visit www.uniflo2.com

Media:
Brittany Tedesco
CPR Communications for Uni-flo2 
btedesco@cpronline.com
201.641.1911 x 14

13 2018 Aug

PRESS RELEASE: Uni-flo2 Single-Nasal Cannula System Announces White Paper Emphasizing Benefits of Single-Nasal Cannula for Patient Dignity, Comfort and Safety

LEHIGH VALLEY, PA – August 13, 2018 –Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, announces the release of its white paper, “Breathe Easier: Single-Prong Cannula Represents Important Breakthrough in Oxygen Therapy for COPD Patients.” Authored by Campbell Cauthen, Registered Respiratory Therapist and co-inventor, Uni-flo2, the paper articulates issues related to the method of delivery of oxygen in supplemental oxygen therapy and highlights the advantages of a breakthrough redesign of the nasal cannula delivery system-- a single-prong nasal cannula -- for people living with COPD.

With the vast number of COPD patients struggling to breathe and requiring low flow supplemental oxygen, the introduction of the discreet, lightweight Uni-flo2Single-nasal Cannula System (Uni-flo2) is a welcome life-changing experience that addresses the majority of the concerns expressed by long term dual nasal prong cannula users,” says Cauthen. “Half the weight, half the skin contact, and twice as discreet, the Uni-flo2conforms to all facial contours and ensures continuous low flow oxygen availability and maximizes patient comfort.

Among the advantages of the Uni-flo2most frequently cited by surveyed COPD patients are:

  • Greater comfort
  • Freedom of movement
  • Avoidance of facial skin irritation
  • Improved sleep
  • Ease of eating
  • Enhanced ability to smell fragrances and food
  • Enhanced personal appearance

For those who are dependent on oxygen, the Uni-flo2, single nasal cannula provides a safe, secure, easy to use, and discreet device,”Cauthen adds. “Not only is it more comfortable and visually attractive than dual-prongedcannulas, it provides equivalent oxygen delivery and reduces the negative effects caused by long term use of the dual prong cannula.”

About Uni-flo2
Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous low flow oxygen flow equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348.  Visit www.uniflo2.com.

Media:
Brittany Tedesco
CPR Communications for Uni-flo2 
btedesco@cpronline.com
201.641.1911 x 14

06 2018 Aug

PRESS RELEASE: Uni-flo2 Single-Nasal Cannula System Offers Significant Improvements for COPD Patients with Summer and Seasonal Allergies

LEHIGH VALLEY, PA – August 6, 2018 – Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, points to its benefits for COPD patients whose symptoms tend to worsen with the onset of seasonal allergies. A study published in the American Journal of Respiratory and Critical Care Medicine found that patients with COPD and seasonal allergies were more likely to exhibit symptoms of wheezing, chronic coughing and phlegm build-up. These individuals were also more likely to visit the doctor for reasons related to their COPD condition.

 “Exposure to an allergen often narrows the airways and increases mucus production, putting COPD patients with respiratory allergies at a greater risk for a flare-up and making breathing even more difficult,” says Campbell Cauthen, Registered Respiratory Therapist and co-inventor, Uni-flo2. “The Uni-flo2 discreet, lightweight single cannula offers patients relief during allergy season by reducing the irritation to the nostrils already inflamed by the allergic response.”

During the heat waves of the summer months, COPD patients will appreciate these frequently cited advantages:

o   Greater comfort

o   Freedom of movement

o   Avoidance of facial skin irritation

o   Less weight from one-half the tubing

o   Reduced feeling of "confinement" by removal of tubing under the chin

“The last thing that COPD patients with allergies need is the uncomfortable tubing from a dual- prong cannula pressing into the cheek, pulling on the ears, and noosing under the chin,” Cauthen adds. “The design of Uni-flo2 Single Nasal Cannula  eliminates these issues, increasing comfort levels throughout the day and night.”

About Uni-flo2

Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous low flow oxygen flow equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348. Visit www.uniflo2.com

Media:
Brittany Tedesco
CPR Communications for Uni-flo2
btedesco@cpronline.com
201.641.1911x14

07 2018 May

Upgraded Website Release

UPODS releases an upgraded Website – Easy to Use!  When users visit the revamped website, launched May 7, 2018, they will find a new design that simplifies the process of ordering, getting clinical support, and viewing instructions for use.  It also features a short video where viewers can access testimonials and learn more about our products via an enhanced FAQ section. The new website is an opportunity to fully examine the attributes of the Uni-floNasal Cannulas which are designed with patient dignity, comfort and safety in mind.

24 2018 Apr

HCPCS Code Assigned

UPODS Uni-flo2  Nasal Cannulas have been assigned HCPCS Coding.  UPODS has received approval and assignment of the following HCPCS Codes for the Uni-flo2 Nasal Cannulas for DME Billing: PS-1004, PS-1007 HCPCS Code A4615.

27 2018 Mar

New Patent Issued for Uni-flo2

UPODS is pleased to announce that it has been issued a second patent on its unique new Uni-flo2 nasal cannula. UPODS holds US Patent No. 9,440,039 issued September 13, 2016 and the additional Patent No. 9,925,348 was issued by the US Patent and Trademark Office on March 27, 2018.  Among other features recognized as unique and inventive by the USPTO, this second patent has a size ratio so that pediatric sized cannulas are also covered.

21 2016 Jul

UPODS presents Poster Presentation at the Georgia Society for Respiratory Care in Savannah, GA

Summary data from a 121 patient study was presented in poster presentation titled,

A COMPARISON OF PULSE OXIMETRY VALUES IN OXYGEN DEPENDENT PATIENT(S), WITH SATISFACTION RATINGS OF DUAL PRONG VS SINGLE PRONG ADULT LOW FLOW NASAL CANNULA(S).

The study looked at the satisfaction and dissatisfaction rates of the single vs. dual prong cannulas, with a likely hood of conversion within a 121 patient population. Comparative POX readings across 1-6 LPM were also observed.  The study found that the single cannula devices provided higher statistically significant POX readings when compared to dual prong POX readings across flow rate categories within a defined patient population and across both continuous and pulse delivery type devices.

Download the Study

01 2016 Jan

Introducing the New Uni-flo2 Single-Prong Oxygen-Delivery System

The new Uni-flo2, single prong oxygen-delivery system is designed to replace the old dual-prong cannula that was introduced back in 1949. Dr. Payton had observed and heard his patients’ problems, then undertook a completely new approach to an apparatus that had become sub-standard medical equipment since its introduction over 60 years ago.

The new Uni-flo2 device is a single-prong nasal cannula that offers a simpler and more reliable performance over the dual prong device currently in use worldwide.

Dual nasal cannulas are used to deliver supplemental low flow oxygen to people in need of respiratory help. Frequently patients using the dual prong devices experience:

  • irritation of interior nostrils
  • sore and irritated upper lips
  • sores around ears
  • constriction around neck
  • displacement of dual prongs from nostrils
  • self-consciousness while wearing dual prong devices (especially in public)
  • removal of device when eating
  • use of protective pads to reduce skin irritation

The old design rests its plastic bulk on the upper lip, has two plastic tubes that run across the cheeks, which tugs the ears, all noosed in front, under tension that leads to much discomfort to patients.

The new Uni-flo2 cannula addresses all of these noted issues and takes those pressures and discomforts away. The single prong Uni-flo2 has a miniaturized double-channel tube that incorporates a memory stabilization system that allows adjustment to all facial contours while lifting the single tube off the skin. The Uni-flo2 cannula incorporates a soft-plus custom designed nasal cavity component (NCC) made of special materials and shapes that insure optimal patient comfort. The NCC as well provides, through one nostril, a near top of main airway delivery, which ensures proper oxygen supply while helping to reduce retrograde flow loss. This single-NCC is interchangeable to either nostril, is non-DEHP construction and does not contain any natural rubber latex, which all reduce patient DEHP exposure while improving patient comfort. The design incorporates multiple strain-relief points to insure continuous gas flow. The Uni-flo2 cannula is half the weight of the dual prong devices and wraps behind the neck hiding the tubing. Patients find it cosmetically appealing. Care-providers believe that through the Uni-flo2 human factors designs and simplicity of use, they will experience increased compliance.

The Uni-flo2 cannula is a superior design that strives to advance patient care, while focusing on caregiver efficiency. With its superior design and construction, the selection of ultra-smooth materials and a complete human factors cutting edge approach to design, we believe we can now provide uninterrupted flow of oxygen in a dignified way to the patients we serve.